Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Oing

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Expert Review of Anticancer Therapy|June 30, 2026
Predictive biomarkers of response in metastatic prostate cancer: paving the way for a new era of precision medicineChiara Mercinelli, Fabrizio Di Costanzo, Christoph Oing, et al.
European Urology|April 28, 2026
European Association of Urology Guidelines on Testicular Cancer: Summary of the 2026 GuidelinesAnna Patrikidou, Walter Cazzaniga, Christoph Oing, et al.
Chinese Clinical Oncology|September 2, 2025
New hormonal agents and integrated strategies for non-metastatic, hormone-sensitive prostate carcinoma: the orphan setting?-a narrative reviewFabrizio Di Costanzo, Iolanda Santa Parisi, Giuseppe Neola, et al.
World Journal of Urology|November 15, 2021
Therapy of clinical stage IIA and IIB seminoma: a systematic reviewJulia Heinzelbecker, Stefanie Schmidt, Julia Lackner, et al.
European Urology|May 14, 2023
European Association of Urology Guidelines on Testicular Cancer: 2023 UpdateAnna Patrikidou, Walter Cazzaniga, Daniel Berney, et al.
Frontiers in Genetics|December 16, 2024
PARP inhibitors in testicular germ cell tumors: what we know and what we are looking forSara Parola, Christoph Oing, Pasquale Rescigno, et al.
European Urology Oncology|February 6, 2025
Redefining Good-prognosis Seminoma: Implications for Clinical Practice of the Updated International Germ Cell Cancer Collaborative Group Classification and Results from the SEMITrends SurveyAnna Patrikidou, Christoph Oing, Christos Markellos, et al.
The Oncologist|November 17, 2025
Best therapeutic approach in metastatic hormone-sensitive prostate cancer based on disease volume: a systematic review and network meta-analysisFabrizio Di Costanzo, Chiara Mercinelli, Alessio Signori, et al.
European Journal of Cancer (Oxford, England : 1990)|May 4, 2020
Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3)Christoph Seidel, Gedske Daugaard, Tim Nestler, et al.
International Journal of Radiation Oncology, Biology, Physics|April 24, 2022
Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation TherapyAngelika Terbuch, Florian Posch, Thomas Bauernhofer, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Expert Review of Anticancer Therapy|June 30, 2026
Predictive biomarkers of response in metastatic prostate cancer: paving the way for a new era of precision medicineChiara Mercinelli, Fabrizio Di Costanzo, Christoph Oing, et al.
European Urology|April 28, 2026
European Association of Urology Guidelines on Testicular Cancer: Summary of the 2026 GuidelinesAnna Patrikidou, Walter Cazzaniga, Christoph Oing, et al.
Chinese Clinical Oncology|September 2, 2025
New hormonal agents and integrated strategies for non-metastatic, hormone-sensitive prostate carcinoma: the orphan setting?-a narrative reviewFabrizio Di Costanzo, Iolanda Santa Parisi, Giuseppe Neola, et al.
World Journal of Urology|November 15, 2021
Therapy of clinical stage IIA and IIB seminoma: a systematic reviewJulia Heinzelbecker, Stefanie Schmidt, Julia Lackner, et al.
European Urology|May 14, 2023
European Association of Urology Guidelines on Testicular Cancer: 2023 UpdateAnna Patrikidou, Walter Cazzaniga, Daniel Berney, et al.
Frontiers in Genetics|December 16, 2024
PARP inhibitors in testicular germ cell tumors: what we know and what we are looking forSara Parola, Christoph Oing, Pasquale Rescigno, et al.
European Urology Oncology|February 6, 2025
Redefining Good-prognosis Seminoma: Implications for Clinical Practice of the Updated International Germ Cell Cancer Collaborative Group Classification and Results from the SEMITrends SurveyAnna Patrikidou, Christoph Oing, Christos Markellos, et al.
The Oncologist|November 17, 2025
Best therapeutic approach in metastatic hormone-sensitive prostate cancer based on disease volume: a systematic review and network meta-analysisFabrizio Di Costanzo, Chiara Mercinelli, Alessio Signori, et al.
European Journal of Cancer (Oxford, England : 1990)|May 4, 2020
Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3)Christoph Seidel, Gedske Daugaard, Tim Nestler, et al.
International Journal of Radiation Oncology, Biology, Physics|April 24, 2022
Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation TherapyAngelika Terbuch, Florian Posch, Thomas Bauernhofer, et al.
Pageof 8